IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 222 filers reported holding IMMUNOGEN INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $76,000 | -38.7% | 16,864 | -35.1% | 0.00% | -25.0% |
| Q1 2022 | $124,000 | -37.4% | 25,966 | -2.3% | 0.00% | -33.3% |
| Q4 2021 | $198,000 | +16.5% | 26,571 | -6.3% | 0.01% | +20.0% |
| Q3 2021 | $170,000 | -15.8% | 28,359 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $202,000 | +2.5% | 28,359 | +11.5% | 0.01% | 0.0% |
| Q1 2021 | $197,000 | +34.0% | 25,427 | +12.3% | 0.01% | -12.5% |
| Q4 2020 | $147,000 | +63.3% | 22,651 | -0.8% | 0.01% | +60.0% |
| Q3 2020 | $90,000 | -11.8% | 22,836 | +3.1% | 0.01% | -28.6% |
| Q2 2020 | $102,000 | -17.1% | 22,139 | -38.4% | 0.01% | -30.0% |
| Q1 2020 | $123,000 | +1950.0% | 35,947 | +3445.1% | 0.01% | – |
| Q4 2014 | $6,000 | -99.9% | 1,014 | +125.3% | 0.00% | -100.0% |
| Q2 2014 | $5,333,000 | – | 450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |